ulcerative colitisThe clinical course of ulcerative colitis (UC), a chronic inflammatory bowel disease, may be different in each patient. Data reported from a recent population-based inception cohort show that a high percentage of cases (55%) have spontaneous remission or mild severity of clinical...
While a minority of patients with ulcerative colitis has primary sclerosing cholangitis (PSC), a significant proportion of patients with PSC have ulcerative colitis. The activity of PSC is usually not commensurate with the degree of concomitant colonic inflammation. Moreover, up to one-third of ...
Remission-inducing potential of centrifugal leukocyte apheresis in refractory patients with active ulcerative colitisrupture of the spleenacute pancreatitischronic pancreatitissplenectomypancreatectomyBackground: Accessory spleen is a common congenital anomaly. There are currently no endoscopic ultrasound (EUS) ...
Berberine (BBR) has been explored as a potential anti-liver fibrosis agent, but the underlying mechanisms are unknown. In the current study, we aimed to investigate the molecular mechanisms underlying the effect of BBR against liver fibrogenesis in thioacetamide (TAA) and carbon tetrachloride (CCl4)...
Sirs, When nonsignificant results are found in trials of meta-analyses, differentiating between no proof of difference (an 'inconclusive' result) and proof of no difference (equivalence, a 'conclusive' result) is increasingly recognised to be a crucial step for a correct interpretation.Alimentary ...
Vijan, S.Waljee, A. K.John Wiley & Sons, LtdAlimentary Pharmacology & TherapeuticsMaratea D, Fadda V, Trippoli S, et al. Letter: biological drugs for inducing remission in ulcerative colitis. Aliment Pharmacol Ther 2014; 39: 1242-4....
(2013) Inducing remission of ulcerative colitis: are clinicians better equipped than ever?. Expert Review of Gastroenterology & Hepatology 7 , 95-97 /AlessandroArmuzzi, CarlaFelice. (2013) Inducing remission of ulcerative colitis: are clinicians better equipped than ever?. Expert Review of ...
Aim of this study was to assess the efficacy and safety of Adalimumab in inducing remission or clinical response in outpatients UC patients treated in Italian primary Inflammatory Bowel Diseases centres. Methods: Fifty-seven consecutive UC patients with at least 12-week follow-up were enrolled. The...
Mirikizumab for inducing and maintaining clinical remission in ulcerative colitisdoi:10.1038/s41575-023-00835-7Jordan,HindsonNature Publishing Group UKNature reviews. Gastroenterology & hepatology
The role of oral vancomycin in inducing remission for biologic-experienced ulcerative colitis with concomitant primary sclerosing cholangitis and liver transplantationLiver transplantationOral vancomycinPrimary sclerosing cholangitisUlcerative colitisWhile a minority of patients with ulcerative colitis has primary ...